SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-004874
Filing Date
2020-02-18
Accepted
2020-02-18 16:20:21
Documents
2
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1561
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4646
  Complete submission text file 0000899243-20-004874.txt   7560
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Cassella James V (Reporting) CIK: 0001353528 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 20625553

Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations